VIA
BLUE

Vident Investment Advisory’s bluebird bio BLUE Stock Holding History

Vident Investment Advisory’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-686
Closed -$43.6K – 1196
2023
Q1 		$43.6K Buy
686
+8
+1% +$914 ﹤0.01% 1209
2022
Q4 		$93.8K Buy
+678
New +$95.5K ﹤0.01% 1111
2022
Q2 		– Sell
-661
Closed -$64K – 1284
2022
Q1 		$64K Sell
661
-147
-18% -$19.4K ﹤0.01% 1244
2021
Q4 		$161K Sell
808
-2,512
-76% -$593K ﹤0.01% 1158
2021
Q3 		$822K Sell
3,320
-741
-18% -$212K 0.02% 741
2021
Q2 		$1.68M Buy
4,061
+1,102
+37% +$437K 0.05% 475
2021
Q1 		$1.16M Hold
2,959
– – 0.04% 572
2020
Q4 		$1.66M Buy
2,959
+1,441
+95% +$913K 0.07% 359
2020
Q3 		$1.06M Sell
1,518
-222
-13% -$173K 0.05% 469
2020
Q2 		$1.38M Buy
1,740
+330
+23% +$249K 0.07% 364
2020
Q1 		$839K Sell
1,410
-19
-1% -$18.5K 0.05% 447
2019
Q4 		$1.62M Buy
1,429
+549
+62% +$597K 0.1% 312
2019
Q3 		$1.05M Sell
880
-25
-3% -$38.2K 0.09% 171
2019
Q2 		$1.49M Sell
905
-284
-24% -$491K 0.12% 121
2019
Q1 		$2.42M Sell
1,189
-30
-2% -$52.8K 0.13% 233
2018
Q4 		$1.57M Buy
1,219
+275
+29% +$422K 0.09% 310
2018
Q3 		$1.79M Sell
944
-98
-9% -$202K 0.07% 350
2018
Q2 		$2.12M Buy
1,042
+281
+37% +$640K 0.08% 320
2018
Q1 		$1.69M Buy
761
+283
+59% +$720K 0.07% 333
2017
Q4 		$1.39M Sell
478
-353
-42% -$717K 0.06% 322
2017
Q3 		$1.48M Buy
831
+45
+6% +$62.9K 0.08% 316
2017
Q2 		$1.07M Sell
786
-176
-18% -$212K 0.09% 314
2017
Q1 		$1.13M Buy
962
+160
+20% +$163K 0.11% 297
2016
Q4 		$641K Sell
802
-473
-37% -$376K 0.08% 325
2016
Q3 		$1.12M Sell
1,275
-12
-0.9% -$8.69K 0.15% 267
2016
Q2 		$722K Sell
1,287
-484
-27% -$274K 0.1% 312
2016
Q1 		$976 Buy
1,771
+823
+87% +$505K 0.06% 350
2015
Q4 		$789K Buy
+948
New +$947K 0.1% 333

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Vident Investment Advisory's BLUE Position: Q2 2023 in Review

Vident Investment Advisory sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 686 shares — an estimated $43.6K sold.

Vident Investment Advisory first reported a position in BLUE in Q4 2015 and held it in 28 quarters. The position peaked at $2.42M in Q1 2019. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

  • Vident Investment Advisory reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 686 bluebird bio shares in Q2 2023, an estimated $43.6K.
  • Vident Investment Advisory first reported a position in bluebird bio in Q4 2015 and held it in 28 quarters.
  • Vident Investment Advisory's bluebird bio position peaked at $2.42M in Q1 2019.
  • 175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.